Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pasteurella multocida antigens are a complex group of molecular structures derived from the Gram-negative bacterium Pasteurella multocida, which causes various severe diseases in livestock and poultry, including fowl cholera and hemorrhagic septicemia (Harper et al., 2006). These antigens primarily include capsular polysaccharides (CPS), which are essential for serogrouping (A, B, D, E, and F) and immune evasion, and lipopolysaccharides (LPS) that contribute to the inflammatory response and endotoxicity (Boyce et al., 2012). Additionally, outer membrane proteins (OMPs) such as OmpA and OmpH are significant targets for the host protective immune response due to their conservation across strains (Hatfaludi et al., 2010). In certain strains, the Pasteurella multocida toxin (PMT) acts as a potent mitogen and virulence factor, making it a critical component for toxoid-based vaccines (Wilson and Ho, 2013). These antigens are utilized in the development of bacterins, subunit vaccines, and recombinant vaccines to stimulate the production of neutralizing antibodies and cellular immunity. The primary therapeutic challenge lies in the antigenic diversity of the species, which often necessitates the use of multivalent vaccines to ensure broad protection against different serotypes (Wilkie et al., 2012).
Induction of active immunity through the presentation of bacterial epitopes to B and T lymphocytes, leading to the production of neutralizing antibodies and immunological memory.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pasteurella multocida antigens (P. multocida antigens).